
Article | Healthcare
Pioneering the future of life sciences with AI
Artificial intelligence (AI) is transforming the future of drug discovery. Accelerated computing with AI has launched an entirely new paradigm that is streamlining the investigation, assessment, and creation of new drugs and therapies. These capabilities can be applied to evidence-based treatments, disease prediction, and prevention, bringing tailored therapies into widespread use. However, the exponential growth of life sciences data has put pressure on organizations to evolve. By 2025, data volumes are expected to reach 200 zettabytes. Although this data holds the potential to enable the next scientific breakthrough, issues including computational bottlenecks, limited access to mission-critical information, and poor predictive validity are major roadblocks on the path to discovery.
HC - Solution Overview - Pioneering the future of life sciences with AI
More articles
Article
4-Step Action Plan To Equip Data Scientists For The Hybrid World
No matter where data teams are working from, they require high-performance computing power. But the quick fixes that IT relied on in the early days of hybrid work—like VDI and VPNs—just aren’t robust enough to meet these users’ compute-intensive needs.
Article
Neural.love harnesses the power of AI to revitalize the past
Neural networks running on the HP Z8 Workstation create more authentic connections with priceless bygone moments.
Solution overview | FSI
Unleasing the future of banking with AI
The banking industry is undergoing a massive shift as companies work to improve the effectiveness of their operations.